MYCN‐amplified neuroblastoma cell‐derived exosomal miR‐17‐5p promotes proliferation and migration of non‐MYCN amplified cells

Weiming Chen,Xiwei Hao,Binyi Yang,Yuezhen Zhang,Lingyun Sun,Li Yang,Jiabin Yu,Jing Zhao,Lin Hou,Hongting Lu,Yanan  Hua
DOI: https://doi.org/10.3892/mmr.2021.11884
IF: 3.423
2021-02-01
Molecular Medicine Reports
Abstract:Neuroblastoma (NB) is considered a highly prevalent extracranial solid tumor in young children, and the upregulation of N‑myc proto‑oncogene (MYCN) is closely associated with the late stages of NB and poor prognostic outcomes. The current study was designed to evaluate the effects of exosomal microRNA (miRNA/miR)‑17‑5p from MYCN‑amplified NB cells on the proliferative and migratory potential of non‑MYCN amplified NB cells. miR‑17‑5p was found to activate the PI3K/Akt signaling cascade by targeting PTEN, and the overexpression of miR‑17‑5p was found to promote cellular migration and proliferation <i>in vitro</i>. Further experimentation revealed that the elevated expression of miR‑17‑5p in SK‑N‑BE(2) cell‑derived exosomes significantly promoted the proliferative and migratory capacities of SH‑SY5Y cells by inhibiting PTEN. Collectively, these findings demonstrated that miR‑17‑5p derived from MYCN‑amplified NB cell exosomes promoted the migration and proliferation of non‑MYCN amplified cells, highlighting an exosome‑associated malignant role for miR‑17‑5p.
oncology,medicine, research & experimental
What problem does this paper attempt to address?